Appili Therapeutics Inc (APLI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 349 | 1,125 | 1,228 | 186 | 665 |
| Receivables | 202 | 515 | 1,671 | 1,759 | 751 |
| TOTAL | $742 | $1,885 | $3,014 | $2,071 | $1,529 |
| Non-Current Assets | |||||
| PPE Net | 12 | 15 | 19 | 22 | 26 |
| TOTAL | $12 | $15 | $19 | $22 | $26 |
| Total Assets | $754 | $1,900 | $3,033 | $2,094 | $1,554 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,614 | 11,649 | 11,558 | 10,473 | 9,608 |
| Accounts payable and accrued liabilities | 4,123 | 4,162 | 4,106 | 4,434 | 4,205 |
| TOTAL | $15,752 | $15,826 | $15,694 | $14,909 | $13,855 |
| Non-Current Liabilities | |||||
| Long Term Debt | 609 | 703 | 736 | 811 | 814 |
| TOTAL | $609 | $703 | $736 | $811 | $814 |
| Total Liabilities | $16,361 | $16,529 | $16,430 | $15,721 | $14,670 |
| Shareholders' Equity | |||||
| Common Shares | 42,323 | 42,323 | 42,323 | 42,323 | 42,323 |
| Retained earnings | -73,956 | -72,967 | -71,718 | -71,946 | -71,422 |
| Other shareholders' equity | 564 | 1,179 | 1,179 | 1,179 | 2,835 |
| TOTAL | $-15,606 | $-14,629 | $-13,397 | $-13,627 | $-13,115 |
| Total Liabilities And Equity | $754 | $1,900 | $3,033 | $2,094 | $1,554 |